Scynexis (SCYX) EBITDA Margin (QoQ) (2013 - 2025)
Scynexis (SCYX) EBITDA Margin (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.56 Bn | 39.90 Bn | 2.15 Bn |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.07 Bn | 19.41 Bn | 683.80 Mn |
| 6 | Viatris | 18.96 Bn | 18.07 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.46 Bn | 15.07 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Scynexis | 62.08 Mn | -52.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257,289.00 |
| Sep 30, 2025 | -181,551.00 |
| Jun 30, 2025 | 264,924.00 |
| Mar 31, 2025 | -252,594.00 |
| Dec 31, 2024 | 73,938.00 |
| Sep 30, 2024 | -30,861.00 |
| Jun 30, 2024 | -56,253.00 |
| Mar 31, 2024 | -29,462.00 |
| Dec 31, 2023 | 17,555.00 |
| Sep 30, 2023 | -66,206.00 |
| Jun 30, 2023 | 103,394.00 |
| Mar 31, 2023 | 52,982.00 |
| Dec 31, 2022 | -7,494.00 |
| Sep 30, 2022 | 24,289.00 |
| Jun 30, 2022 | 117,663.00 |
| Mar 31, 2022 | 91,513.00 |
| Dec 31, 2021 | 3,279.00 |
| Jun 30, 2019 | -110,929.00 |
| Mar 31, 2019 | -479,844.00 |
| Dec 31, 2018 | -388,750.00 |